Escitalopram effects on insula and amygdala BOLD activation during emotional processing

[1]  John Suckling,et al.  Brain Imaging Correlates of Depressive Symptom Severity and Predictors of Symptom Improvement After Antidepressant Treatment , 2007, Biological Psychiatry.

[2]  P. Cowen,et al.  A single dose of citalopram increases fear recognition in healthy subjects , 2007, Journal of psychopharmacology.

[3]  John Suckling,et al.  Neural responses to happy facial expressions in major depression following antidepressant treatment. , 2007, The American journal of psychiatry.

[4]  Justin S. Feinstein,et al.  Increased amygdala and insula activation during emotion processing in anxiety-prone subjects. , 2007, The American journal of psychiatry.

[5]  Justin S. Feinstein,et al.  Lorazepam dose-dependently decreases risk-taking related activation in limbic areas , 2006, Psychopharmacology.

[6]  M. Paulus,et al.  An Insular View of Anxiety , 2006, Biological Psychiatry.

[7]  Murray B. Stein,et al.  Anticipation of Aversive Visual Stimuli Is Associated With Increased Insula Activation in Anxiety-Prone Subjects , 2006, Biological Psychiatry.

[8]  M. Jessa,et al.  Prediction of anti-panic properties of escitalopram in the dorsal periaqueductal grey model of panic anxiety , 2006, Neuropharmacology.

[9]  Guy M. Goodwin,et al.  Antidepressant Drug Treatment Modifies the Neural Processing of Nonconscious Threat Cues , 2006, Biological Psychiatry.

[10]  Enrico Simonotto,et al.  The effects of escitalopram on working memory and brain activity in healthy adults during performance of the n-back task , 2006, Psychopharmacology.

[11]  R. Elliott,et al.  Serotonergic modulation of neuronal responses to behavioural inhibition and reinforcing stimuli: an fMRI study in healthy volunteers , 2006, The European journal of neuroscience.

[12]  D. S. Zahm,et al.  Specificity in the Projections of Prefrontal and Insular Cortex to Ventral Striatopallidum and the Extended Amygdala , 2005, The Journal of Neuroscience.

[13]  F. Larsen,et al.  The Pharmacokinetics of Escitalopram After Oral and Intravenous Administration of Single and Multiple Doses to Healthy Subjects , 2005, Journal of clinical pharmacology.

[14]  J L Carrasco,et al.  Clinical effects of pharmacological variations in selective serotonin reuptake inhibitors: an overview , 2005, International journal of clinical practice.

[15]  Rebecca Elliott,et al.  The Effect of Citalopram Pretreatment on Neuronal Responses to Neuropsychological Tasks in Normal Volunteers: An fMRI Study , 2005, Neuropsychopharmacology.

[16]  R. Elliott,et al.  Neuronal effects of acute citalopram detected by pharmacoMRI , 2005, Psychopharmacology.

[17]  Justin S. Feinstein,et al.  Dose-dependent decrease of activation in bilateral amygdala and insula by lorazepam during emotion processing. , 2005, Archives of general psychiatry.

[18]  J. Lorberbaum,et al.  Neural correlates of speech anticipatory anxiety in generalized social phobia , 2004, Neuroreport.

[19]  A. Simmons,et al.  Anticipation of emotionally aversive visual stimuli activates right insula , 2004, Neuroreport.

[20]  John Suckling,et al.  Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. , 2004, Archives of general psychiatry.

[21]  P. Cowen,et al.  Increased Positive versus Negative Affective Perception and Memory in Healthy Volunteers following Selective Serotonin and Norepinephrine Reuptake Inhibition , 2022 .

[22]  M. Schlund,et al.  Effects of citalopram on worry and brain activation in patients with generalized anxiety disorder , 2004, Psychiatry Research: Neuroimaging.

[23]  H. Critchley,et al.  Neural systems supporting interoceptive awareness , 2004, Nature Neuroscience.

[24]  Katherine McMullin,et al.  Amygdala and insular responses to emotionally valenced human faces in small animal specific phobia , 2003, Biological Psychiatry.

[25]  S. Rauch,et al.  Neurobiology of emotion perception I: the neural basis of normal emotion perception , 2003, Biological Psychiatry.

[26]  D. Charney,et al.  Neuroanatomical circuits modulating fear and anxiety behaviors , 2003, Acta psychiatrica Scandinavica. Supplementum.

[27]  Corianne Rogalsky,et al.  Increased activation in the right insula during risk-taking decision making is related to harm avoidance and neuroticism , 2003, NeuroImage.

[28]  M. Papp,et al.  R-citalopram counteracts the effect of escitalopram in a rat conditioned fear stress model of anxiety , 2003, Pharmacology Biochemistry and Behavior.

[29]  C. Sánchez,et al.  Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities , 2003, Psychopharmacology.

[30]  P. Cowen,et al.  Tryptophan depletion decreases the recognition of fear in female volunteers , 2003, Psychopharmacology.

[31]  Lisa M Shin,et al.  Neuroimaging Studies of Amygdala Function in Anxiety Disorders , 2003, Annals of the New York Academy of Sciences.

[32]  M. Vaswani,et al.  Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[33]  D. Perrett,et al.  Acute SSRI Administration Affects the Processing of Social Cues in Healthy Volunteers , 2003, Neuropsychopharmacology.

[34]  K. Goa,et al.  Escitalopram , 2003, CNS drugs.

[35]  C. Carter,et al.  Tryptophan Depletion Alters the Decision-Making of Healthy Volunteers through Altered Processing of Reward Cues , 2003, Neuropsychopharmacology.

[36]  J. O'Doherty,et al.  Appetitive and Aversive Olfactory Learning in Humans Studied Using Event-Related Functional Magnetic Resonance Imaging , 2002, The Journal of Neuroscience.

[37]  Gregory G. Brown,et al.  Increased amygdala activation to angry and contemptuous faces in generalized social phobia. , 2002, Archives of general psychiatry.

[38]  A. Craig.  How do you feel? Interoception: the sense of the physiological condition of the body , 2002, Nature Reviews Neuroscience.

[39]  Monique Ernst,et al.  Decision-making in a Risk-taking Task: A PET Study , 2002, Neuropsychopharmacology.

[40]  M. Mintun,et al.  Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study , 2001, Biological Psychiatry.

[41]  Thomas J. Ross,et al.  Amygdala response to both positively and negatively valenced stimuli , 2001, Neuroreport.

[42]  P. Jerabek,et al.  Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response , 2000, Biological Psychiatry.

[43]  J. Gabrieli,et al.  Event-Related Activation in the Human Amygdala Associates with Later Memory for Individual Emotional Experience , 2000, The Journal of Neuroscience.

[44]  J L Lancaster,et al.  Automated Talairach Atlas labels for functional brain mapping , 2000, Human brain mapping.

[45]  Lisa M Shin,et al.  Exaggerated amygdala response to masked facial stimuli in posttraumatic stress disorder: a functional MRI study , 2000, Biological Psychiatry.

[46]  J. Price,et al.  The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans. , 2000, Cerebral cortex.

[47]  S. Rauch,et al.  Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. , 1999, The American journal of psychiatry.

[48]  P. Masand,et al.  Selective serotonin-reuptake inhibitors: an update. , 1999, Harvard review of psychiatry.

[49]  D. Nutt,et al.  Mechanisms of action of selective serotonin reuptake inhibitors in the treatment of psychiatric disorders , 1999, European Neuropsychopharmacology.

[50]  H. Breiter,et al.  Functional Magnetic Resonance Imaging of Brain Reward Circuitry in the Human , 1999, Annals of the New York Academy of Sciences.

[51]  Joseph E LeDoux,et al.  GABAergic Antagonists Block the Inhibitory Effects of Serotonin in the Lateral Amygdala: A Mechanism for Modulation of Sensory Inputs Related to Fear Conditioning , 1999, The Journal of Neuroscience.

[52]  J. Mendlewicz.  Predicting response: serotonin reuptake inhibition. , 1999, International clinical psychopharmacology.

[53]  L. Parsons,et al.  Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. , 1999, The American journal of psychiatry.

[54]  George Bush,et al.  The emotional counting stroop paradigm: a functional magnetic resonance imaging probe of the anterior cingulate affective division , 1998, Biological Psychiatry.

[55]  J. Gorman,et al.  Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety , 1998, Biological Psychiatry.

[56]  A. Young,et al.  Neural responses to facial and vocal expressions of fear and disgust , 1998, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[57]  V J Cunningham,et al.  Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study. , 1998, Archives of general psychiatry.

[58]  Karl J. Friston,et al.  Brain systems mediating aversive conditioning: An event related fMRI study , 1998, NeuroImage.

[59]  R. Mattick,et al.  Development and validation of measures of social phobia scrutiny fear and social interaction anxiety. , 1998, Behaviour research and therapy.

[60]  Karl J. Friston,et al.  A neuromodulatory role for the human amygdala in processing emotional facial expressions. , 1998, Brain : a journal of neurology.

[61]  Nathaniel M. Alpert,et al.  The functional neuroanatomy of anxiety: a study of three disorders using positron emission tomography and symptom provocation , 1997, Biological Psychiatry.

[62]  M. Torrens.  Co-Planar Stereotaxic Atlas of the Human Brain—3-Dimensional Proportional System: An Approach to Cerebral Imaging, J. Talairach, P. Tournoux. Georg Thieme Verlag, New York (1988), 122 pp., 130 figs. DM 268 , 1990 .

[63]  M. J. Norušis,et al.  SPSS base system user's guide , 1990 .

[64]  L. Derogatis,et al.  The Brief Symptom Inventory: an introductory report , 1983, Psychological Medicine.

[65]  C. Spielberger,et al.  Manual for the State-Trait Anxiety Inventory , 1970 .

[66]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.